Anna Sussman | VP, IR |
Patrick Mahaffy | Co-Founder, CEO, President & Executive Director |
Daniel Muehl | EVP & CFO |
Lindsey Rolfe | EVP, Clinical, Preclinical Development & Pharmacovigilance and Chief Medical Officer |
Kennen MacKay | RBC Capital Markets |
Gavin Scott | JPMorgan Chase & Co. |
Ladies and gentlemen, thank you for standing by, and welcome to the Clovis Oncology Second Quarter 2020 Financial Results Webcast and Conference Call. (Operator Instructions) I would now like to hand the conference over to your speaker today, Anna Sussman, VP of Investor Relations. Thank you. Please go ahead.
Thank you, Judy.